Feasibility - phase I development of a next generation (reduced processing time) pathogen reduction and blood safety system

Ended Project Grant Awarded Last action

Award ID
W81XWH1710381
Recipient
Awarding agency
Obligated
$3,225,374

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Denver, CO 80215, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Feasibility-phase development of a next-generation (reduced processing time) pathogen reduction andblood safety system DE-obligate funds to close out award -$1,447,263
Amendment Feasibility phase I development of next generation (reduced processing time) pathogen reduction and blood safety system change of principal investigator $0
Amendment Feasibility phase I development of a next generation (reduced process time) pathogen reduction and blood safety system change of principal investigator $0
Amendment $0
Amendment Feasibiity - phase 1 development of a next generation (reduced processing time) pathogen reduction and blood safety system incorporate revised statement of work $0
Original award $4,672,637

Quick answers

Who received award W81XWH1710381?

W81XWH1710381 was awarded to Terumo BCT Biotechnologies, LLC by Medical Command (Department of the Army) on August 1, 2017.

How much is award W81XWH1710381 worth?

$3,225,374 has been obligated on W81XWH1710381.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login